Retisert Bausch & Lomb - Treatment for Chronic Non-Infectious Uveitis

Retisert is an intravitreal implant containing a tiny reservoir of the anti-inflammatory corticosteroid fluocinolone acetonide, which is delivered for approximately two-and-a-half years directly to the back of the eye. Retisert is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Posted: April 2005

Retisert (fluocinolone acetonide) FDA Approval History

View comments

Hide
(web2)